<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0005">
 <label>5</label>
 <mixed-citation publication-type="journal" id="CIT0005-gen-2">(a) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Mehndiratta</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Pan</surname>
    <given-names>SL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kumar</surname>
    <given-names>S</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Indole-3-ethylsulfamoylphenylacrylamides with potent anti-proliferative and anti-angiogenic activities</article-title>. 
  <source>Anticancer Agents Med Chem</source>
  <year>2016</year>;
  <volume>16</volume>:
  <fpage>907</fpage>–
  <lpage>13</lpage>.
  <pub-id pub-id-type="pmid">26459769</pub-id>
 </mixed-citation>
 <mixed-citation publication-type="journal" id="CIT0005-gen-3">(b) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Huang</surname>
    <given-names>YC</given-names>
   </name>, 
   <name name-style="western">
    <surname>Huang</surname>
    <given-names>FI</given-names>
   </name>, 
   <name name-style="western">
    <surname>Mehndiratta</surname>
    <given-names>S</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Anticancer activity of MPT0G157, a derivative of indolylbenzenesulfonamide, inhibits tumor growth and angiogenesis</article-title>. 
  <source>Oncotarget</source>
  <year>2015</year>;
  <volume>6</volume>:
  <fpage>18590</fpage>–
  <lpage>601</lpage>.
  <pub-id pub-id-type="pmid">26087180</pub-id>
 </mixed-citation>
</ref>
